ESP Pharma Overview
- Year Founded
-
2000
- Status
-
Acquired/Merged
- Employees
-
80
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$486M
ESP Pharma General Information
Description
Developer of specialty pharmaceutical products designed to enhance the quality of therapeutics available to healthcare professionals. The company's specialty pharmaceutical products include therapeutics for high blood pressure and angina and late-stage development specialty drugs for bone marrow transplants, enabling patients to achieve improved outcomes in the acute-care setting.
Contact Information
Website
www.esppharma.comCorporate Office
- 2035 Lincoln Highway
- Suite 2150
- Edison, NJ 08817
- United States
Corporate Office
- 2035 Lincoln Highway
- Suite 2150
- Edison, NJ 08817
- United States
ESP Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 24-Mar-2005 | $486M | Completed | Profitable | ||
| 3. Debt - General | 08-Oct-2003 | Completed | Profitable | |||
| 2. Early Stage VC (Series B) | 16-Apr-2003 | $28M | Completed | Profitable | ||
| 1. Early Stage VC (Series A) | 01-Apr-2002 | $28M | $28M | Completed | Profitable |
ESP Pharma Signals
ESP Pharma Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alta Partners | Venture Capital | Minority | ||
| Apax Partners | PE/Buyout | Minority | ||
| Canterbury Capital (South Carolina) | Venture Capital | Minority | ||
| Cressey & Company | PE/Buyout | Minority | ||
| Domain Associates | Venture Capital | Minority |
ESP Pharma FAQs
-
When was ESP Pharma founded?
ESP Pharma was founded in 2000.
-
Where is ESP Pharma headquartered?
ESP Pharma is headquartered in Edison, NJ.
-
What is the size of ESP Pharma?
ESP Pharma has 80 total employees.
-
What industry is ESP Pharma in?
ESP Pharma’s primary industry is Pharmaceuticals.
-
Is ESP Pharma a private or public company?
ESP Pharma is a Private company.
-
What is the current valuation of ESP Pharma?
The current valuation of ESP Pharma is .
-
What is ESP Pharma’s current revenue?
The current revenue for ESP Pharma is .
-
How much funding has ESP Pharma raised over time?
ESP Pharma has raised $85M.
-
Who are ESP Pharma’s investors?
Alta Partners, Apax Partners, Canterbury Capital (South Carolina), Cressey & Company, and Domain Associates are 5 of 9 investors who have invested in ESP Pharma.
-
When was ESP Pharma acquired?
ESP Pharma was acquired on 24-Mar-2005.
-
Who acquired ESP Pharma?
ESP Pharma was acquired by PDL BioPharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process